Aurelia Bioscience Limited and Charnwood Molecular Limited - both in Administration

Please note the final account was delivered to creditors 27 October 2025 at which point the Administrators ceased to act. We anticipate the Company will be dissolved in three months.

On 29 October 2024, Ross Connock and Edward Williams of PricewaterhouseCoopers LLP were appointed as Joint Administrators of Aurelia Bioscience Limited and Charnwood Molecular Limited - together “the Companies”.

On appointment, the Companies’ business and assets were sold to Concept Life Sciences Integrated Discovery & Development Services Limited. The transaction preserved the jobs of 97 of the Companies’ employees, significantly mitigating preferential claims in the administrations. The sale also maximised the value in the Companies’ assets for the benefit of the creditors, which would have been significantly diminished in the event the Companies were wound up. 

If you are a supplier with an outstanding order, and you want to make a claim subject to retention of title for stock or assets hired or rented by the Companies, please contact: uk_aurelia_creditors@pwc.com or uk_charnwood_creditors@pwc.com as appropriate.

The following exchange rates were applied when admitting the claims which were submitted in foreign currency. The exchange rate applied was based on the exchange rate on the date of the appointment of the joint administrators on 29 October 2024.

_{Ross D Connock and Edward Williams have been appointed as Joint Administrators of Aurelia Bioscience Limited and Charnwood Molecular Limited to manage their affairs, business and property, and act without personal liability.  Both are licensed in the United Kingdom to act as insolvency practitioners by the Institute of Chartered Accountants in England and Wales.}  

_{The Joint Administrators are bound by the Insolvency Code of Ethics which can be found at:}

_{https://www.gov.uk/government/publications/insolvency-practitioner-code-of-ethics}

_{The Joint Administrators may act as controllers of personal data as defined by UK data protection law depending upon the specific processing activities undertaken. PricewaterhouseCoopers LLP may act as a processor on the instructions of the Joint Administrators. Personal data will be kept secure and processed only for matters relating to the Joint Administrators’ appointment. Further details are available in the privacy statement on the PwC.co.uk website or by contacting the Joint Administrators.}